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E-mail: srmehta@ucsd.eduWe read with interest the recent report by Ulger Toprak et al.
[1] reporting the ﬁrst case of Butyricimonas virosa bacteraemia
published earlier this year. Here we describe the case of a 72-
year-old man with colon cancer who presented with septic
shock after aortic aneurysm surgery, with Butyricimonas virosa
recovered from blood cultures. This anaerobic bacteria and
related species had been previously described in rat and human
faecal material [2,3] but never before in an infectious context in
humans. The authors point out that this Gram-negative
anaerobic bacterium produced catalase, was inhibited on Bac-
teroides bile aesculin agar and was resistant to kanamycin (1 mg),
vancomycin (5 μg) and colistin sulfate (10 μg). This phenotypic
features were suggestive of a Prevotella spp. However, 16S
rRNA sequencing demonstrated a 99% nucleotide identity with
B. virosa [1].
Recently we also identiﬁed a case of B. virosa bacteraemia in a
81-year-old male veteran who developed a fever 18 days after a
Whipple procedure for adenocarcinoma of the duodenum.
Two sets of blood samples were drawn for culture. Gram-
negative rods were isolated from the anaerobic blood culture
bottle of one set during the ﬁfth day of incubation, after masked
subculture of a blood culture bottle triggering positive with aNew Microbes and New Infections published by El
This is an open access artinegative Gram stain. Consistent with the report of Ulger
Toprak et al. [1], our isolate grew anaerobically on Brucella
blood agar (Becton Dickinson, Franklin Lakes, NJ, USA), and on
Gram stain appeared as a small Gram-negative rod. Our isolate
was catalase positive and was resistant to kanamycin (1 mg),
vancomycin (5 μg) and colistin sulfate (10 μg). Utilizing RapID
Ana testing (bioMérieux, Marcy l’Étoile, France), the isolate was
found to be positive for β-galactosidase, N-acetyl-β-glucosami-
nidase, indole, leucyl glycine and pyroglutamic acid arylamidase,
as was the previously reported isolate; however, a conclusive
identiﬁcation could not be made. The isolate was then evaluated
by matrix-assisted laser desorption/ionization time-of-ﬂight
mass spectrometry (MALDI-TOF) (MicroFlex LT; Bruker Dal-
tonics, Leipzig, Germany) with and without a formic acid
extraction. Vitek MS identiﬁed three separate colonies of the
bacterium as Butyricimonas virosa (score = 2.531, MALDI Bio-
typer 3.1). Our patient recovered without antimicrobial
treatment.
Molecular identiﬁcation technologies such as 16S rRNA
sequencing and MALDI-TOF provide microbiologists with a
much richer understanding of clinical anaerobic bacteriology.
Without MALDI-TOF, we would not have correctly identiﬁed
this organism. Proper identiﬁcation of signiﬁcant isolates may
help to better deﬁne the relationships between particular
pathogens and clinical syndromes.Conﬂict of interestNone declared.References[1] Ulger Toprak N, Bozan T, Birkan Y, Isbir S, Soyletir G. Butyricimonas
virosa: the ﬁrst clinical case of bacteraemia. New Microbes New Infect
2015;4:7–8.
[2] Sakamoto M, Tanaka Y, Benno Y, Ohkuma M. Butyricimonas faecihominis
sp. nov. and Butyricimonas paravirosa sp. nov., isolated from human
faeces, and emended description of the genus Butyricimonas. Int J Syst
Evol Microbiol 2014;64(pt 9):2992–7.
[3] Sakamoto M, Takagaki A, Matsumoto K, Kato Y, Goto K, Benno Y.
Butyricimonas synergistica gen. nov., sp. nov. and Butyricimonas virosa sp.
nov., butyric acid–producing bacteria in the family ‘Porphyromonadaceae’
isolated from rat faeces. Int J Syst Evol Microbiol 2009;59(pt 7):
1748–53.New Microbe and New Infect 2015; 8: 127
sevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases
cle under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)
http://dx.doi.org/10.1016/j.nmni.2015.10.011
DOI of original article: http://dx.doi.org/10.1016/j.nmni.2014.12.004
